NeilMarkRichtandMDPhD

PubMed

• 187 citations
  Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder.
  Robert K. McNamara, Chang-Gyu Hahn, Ronald J. Jandacek, Therese Rider, Patrick Tso
  Biological Psychiatry. 2007-07-01
• 70 citations
  Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.
  Neil M. Richtand
  Neuropsychopharmacology. 2006-07-19
• 100 citations
  Dopamine and serotonin receptor binding and antipsychotic efficacy.
  Neil M. Richtand, Jeffrey A. Welge, Aaron D Logue, Paul E. Keck, Stephen M. Strakowski
  Neuropsychopharmacology. 2007-08-01

Journal Articles

• Antipsychotic medications, glutamate, and cell death: a hidden, but common medication side effect?  
  Isom, A., Gudelsky,G., Benoit, S. and Richtand, N.M., Medical Hypotheses, 1/1/2013
• Evidence for involvement of nitric oxide and GABAB receptors in MK-801-stimulated release of glutamate in rat prefrontal cortex  
  Roenker NL, Gudelsky GA, Ahlbrand R, Horn PS, Richtand NM, Neuropharmacology, 1/1/2012
• Prenatal immune challenge in rats: Altered responses to dopaminergic and glutamatergic agents in the absence of effects on cognition, anxiety, or acoustic startle  
  C.V. Vorhees, D. L. Graham, N. M. Richtand, and M. T. Williams, Synapse, 1/1/2012
• Effects of prenatal immune activation and stress on conditioned place preference to amphetamine  
  Richtand, N.M., Ahlbrand, R., Horn, P.S., Chambers, B., and Benoit, S., Psychopharmacology, 1/1/2012
• Fluoxetine and Aripiprazole Treatment Following Prenatal Immune Activation Exert Longstanding Effects on Rat Locomotor Response  
  Richtand, N.M., Ahlbrand, R., Horn, P., Tambyraja,R., Grainger, M., Bronson, S. L. and McNamara, R.K., Physiology and Behavior, 1/1/2012
• Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801  
  Roenker,N. L., Gudelsky,G., Ahlbrand, R., Bronson, S. L., Kern, J. R., Waterman, H. and Richtand, N.M., Neuroscience Letters, 1/1/2011
• Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors  
  Bronson, S. L., Ahlbrand, R., Horn, P.S., Kern, J. R., and Richtand, N.M., Behavioral Brain Research, 1/1/2011
• Effects of Risperidone and Paliperidone Pretreatment on Locomotor Response Following Prenatal Immune Activation  
  Richtand NM, Ahlbrand R, Horn P, Stanford K, Bronson SL, and McNamara RK, Journal of Psychiatric Research, 1/1/2011
• Neuroplasticity in the mesolimbic system induced by natural reward and subsequent reward abstinence  
  Pitchers KK, Balfour ME, Lehman MN, Richtand NM, Yu L, Coolen LM, Biological Psychiatry, 1/1/2010
• Bimodal Effect of Amphetamine on Motor Behaviors in C57BL/6 Mice  
  Yates, J.W., Meij, J.T.A., Sullivan, J.R., Richtand, N.M., and Yu, L., Neuroscience Letters, 1/1/2007
• Abnormalities in the Fatty Acid Composition of the Postmortem Orbitofrontal Cortex of Schizophrenic Patients: Gender Differences and Partial Normalization with Antipsy...  
  R.K. McNamara, R. Jandacek, T. Rider, P. Tso, C.-G. Hahn, N.M. Richtand and K. Stanford, Schizophrenia Research, 1/1/2007
• Selective Deficits in the Omega-3 Fatty Acid Docosahexaenoic Acid in the Postmortem Orbitofrontal Cortex of Patients with Major Depressive Disorder  
  McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P, Stanford KE, and Richtand NM, Biological Psychiatry, 1/1/2007
• C57BL/6J Mice Exhibit Reduced Dopamine D3 Receptor-Mediated Inhibitory Function Relative to DBA/2J Mice  
  R. K. McNamara, B. Levant, B. Taylor, R. Ahlbrand, Y. Liu, J. R. Sullivan, Stanford, K. and N. M. Richtand, Neuroscience, 1/1/2006
• Relative Expression of D3 Dopamine Receptor and Alternative Splice Variant D3nf mRNA in High and Low Responders to Novelty  
  L.M. Pritchard, A.D. Logue, B.C. Taylor, R. Ahlbrand, J.A. Welge, Y. Tang, F.R. Sharp, and N.M. Richtand, Brain Research Bulletin, 1/1/2006
• Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics  
  Grimm, S.W., Richtand, N.M., Winter, H. R., Stams, K. R., and Reele, S.B., Br. J. Clin. Pharmacol, 1/1/2006
• Expression of the Glucocorticoid Induced Receptor (GIR) mRNA in rat brain  
  Renu Sah, Laurel Pritchard, Neil M. Richtand, Katherine Eaton, Floyd R. Sallee and James P. Herman, Neuroscience, 1/1/2005
• Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1  
  Tang Y, Lu A, Ran R, Aronow BJ, Schorry EK, Hopkin RJ, Gilbert DL, Glauser TA, Hershey AD, Richtand NW, Privitera M, Dalvi A, Sahay A, Szaflarski JP, Ficker DM, Ratner..., Brain Res Mol Brain Res, 1/1/2004
• 7-OH-DPAT and PD 128907 selectively activate D3 dopamine receptor in a novel environment  
  Pritchard, L.M., Logue, A.D., Hayes, S., Welge, J.A., Xu, M., Zhang, J., Berger, S. P. and Richtand, N.M., Neuropsychopharmacology, 1/1/2003
• Stress and amphetamine induces Fos expression in medial prefrontal cortex neurons containing glucocorticoid receptors  
  Ostrander, M.M., Richtand, N.M. and Herman , J.P., Brain Research, 1/1/2003
• What makes a drug a primary mood stabilizer?  
  Keck, P.E., McElroy, S.L., Richtand, N.M. and Tohen, M., Molecular Psychiatry, 1/1/2002
• Regression modeling of rodent locomotion data  
  Welge, J.A. and Richtand, N.M., Behavioral Brain Research, 1/1/2002
• D3 dopamine receptor, behavioral sensitization, and psychosis  
  Richtand, N.M., Woods, S.C., Berger, S.P. and Strakowski, S.M., Neuroscience and Biobehavioral Reviews, 1/1/2001
• The D3 dopamine receptor and substance dependence  
  Richtand, N.M., Goldsmith, R.J., Nolan, J.E. and Berger, S.P., Journal of Addictive Diseases, 1/1/2001
• The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine  
  Richtand, N.M., Logue, A.D., Welge, J.A., Perdiue, J., Tubbs, L.J., Spitzer, R.H., Sethuraman, G. and Geracioti, T.D., Brain Research, 1/1/2000
• Olfactory receptor neurons express D2 dopamine receptors  
  Koster, N.L., Norman, A.B., Richtand, N.M., Nickell, W.T., Puche, A.C., Pixley, S.K. and Shipley, M.T., Journal of Comparative Neurology, 1/1/1999
• Join now to see all

Books/Book Chapters

• Polypharmacy in Clinical Practice 
  Chapter: Receptor binding targets for antipsychotic efficacy. 
  Grainger, M.M., Ahlbrand, R., Horn, P.S. and Richtand NM.Editors: Ritsner, Michael S..Springer, New York2013
• Handbook of Schizophrenia Spectrum Disorders, Volume I. Conceptual Issues and Neurobiological Advances 
  Chapter: Developmental Consequences of Prenatal Immune Activation. 
  Bronson SL and Richtand NMEditors: Ritsner, Michael S..Springer, New York2011
• Progress in Brain Research' Series, Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance 
  Chapter: Serotonin and Dopamine Interactions in Psychosis Prevention. 
  Page 141 - 153Neil M. Richtand and Robert K. McNamaraEditors: Di Giovanni, G., Di Matteo, V., and Esposito, E..Elsevier B.V. Press, Amsterdam, The Netherlands2008
• Progress in Brain Research' Series, Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance 
  Chapter: Role of Serotonin and Dopamine Receptor Binding in Antipsychotic Efficacy. 
  Page 155 - 175Richtand NM, Welge JA, Logue AD, Keck PE Jr, Strakowski SM, and McNamara RKEditors: Di Giovanni, G., Di Matteo, V., and Esposito, E..Elsevier B.V. Press, Amsterdam, The Netherlands2008
• Dopamine and Glutamate in Psychiatric Disorders 
  Chapter: Dopamine Receptor Alternative Splicing. 
  Page 45 - 61Richtand NM, Pritchard LM, Coolen LMEditors: Schmidt WJ, Reith MEA.Humana Press, Totowa, NJ2005
• Methods in Molecular Medicine' Series, Drugs of Abuse: Analysis of Neurological Effects 
  Chapter: Analysis of gene expression in striatal tissue by multiprobe RNase protection assay. 
  Page 181 - 192Richtand, N.M., John M. WalkerEditors: Wang, J. Q..Humana Press, Totowa, NJ2003
• Methods in Molecular Medicine' Series, Drugs of Abuse: Analysis of Neurological Effects 
  Chapter: Laboratory analysis of behavioral effects of drugs of abuse in rodents. 
  Page 475 - 480Richtand, N.M., John M. WalkerEditors: Wang, J. Q..Humana Press, Totowa, NJ2003
• Vitamin D: Biochemical, chemical and clinical aspects related to calcium metabolism, (Proceedings of the Third Workshop in Vitamin D, Asilomar, Calif., Jan. 1977) 
  Chapter: Conversion of 7-dehydrocholesterol to vitamin D3 in vivo: isolation and identification of previtamin D3 from skin. 
  Page 135 - 137Holick, M.F., Frommer, J., McNeill, S., Richtand, N.M., Henley, J. and Potts, J.T. Jr.Editors: A.W. Norman, K. Schaefer, Walter de Gruyter.New York1977
• Join now to see all

Abstracts/Posters

• Evidence for involvement of nitric oxide and GABA-B receptors in MK-801-stimulated glutamate efflux in the rat prefrontal cortex.
  Gudelsky GA, Roenker NL, Ahlbrand R, Horn PS, Richtand NM, Meeting of the American College of Neuropsychopharmacology, 1/1/2012
• Combined effects of antipsychotic medication and hypoglycemia upon microglial activation.
  N.M. Richtand, A.M. Isom, R. Ahlbrand, and G.A. Gudelsky, Meeting of the American College of Neuropsychopharmacology, 1/1/2012
• The impact of combining antipsychotic medications and hypoglycemia on neuronal death and microglial activation.
  A.M. Isom, R. Ahlbrand, and N.M. Richtand, Society for Neuroscience, 1/1/2012
• Prenatal immune activation alters GAD expression in the brains of offspring.
  S.N. Casella, A.M. Hemmerle, K.H. Lundgren, T.L. Kyser, R. Ahlbrand, S.L. Bronson, N.M. Richtand, K.B. Seroogy, Society for Neuroscience, 1/1/2012
• Maternal immune activation alters the effects of stress on amphetamine-stimulated locomotion.
  S.L. Bronson, R. Ahlbrand, J.P. Herman, A.M. Isom, B.A. Packard, and N.M. Richtand, Society for Neuroscience, 1/1/2011
• Behavioral and Cellular Consequences of Concurrent Antipsychotic Administration and Hypoglycemia.
  A.M. Isom, G.A. Gudelsky, R. Ahlbrand, M. Grainger, S.L. Bronson, N.M. Richtand, Society for Neuroscience, 1/1/2011
• The effects of pramipexole on locomotor activity in D3 mutant mice.
  Neil M. Richtand, Wei-li Chang, Rebecca Ahlbrand, Neal R. Swerdlow, Society for Neuroscience, 1/1/2011
• Antipsychotics, Hypoglycemia, and Glutamate: A Deadly Triad?
  Amanda Isom, Gary Gudelsky, Rebecca Ahlbrand, Stephen Benoit, and Neil Richtand, Soc. for Biological Psychiatry, 1/1/2011
• The antipsychotics risperidone and paliperidone reduce extracellular glutamate in the prefrontal cortex of rats treated with MK-801 or in rats exposed prenatally to im...
  N. L. Roenker, R. Ahlbrand, D. Lindquist, N. Richtand, G. A. Gudelsky, Society for Neuroscience, 1/1/2010
• Glutamate-dopamine interactions in a maternal immune activation model with relevance to schizophrenia.
  Bronson, S. L., Ahlbrand, R., Horn, P.S., Kern, J. R., and Richtand, N.M., Soc. for Biological Psychiatry, 1/1/2010
• Early Intervention In A Hypoglutamatergic Model With Relevance To Schizophrenia.
  Neil Richtand, Nicole Roenker, Diana Lindquist, Rebecca Ahlbrand, and Gary Gudelsky, Soc. for Biological Psychiatry, 1/1/2010
• Prenatal immune activation effects upon conditioned place preference to amphetamine.
  N. M. Richtand, R. Ahlbrand, P. Horn, B. Chambers, J. Davis, S. Benoit, Society for Neuroscience, 1/1/2010
• Developmental Exposure to Stress and Amphetamine Following Prenatal Immune Activation.
  Neil M. Richtand, Rebecca Ahlbrand, Paul S. Horn, Joseph R. Kern, and Stefanie L. Bronson, Meeting of the American College of Neuropsychopharmacology, 1/1/2009
• Modulation of the schizophrenia susceptibility genes ErbB4 and BDNF in rats exposed to prenatal immune activation.
  A. M. Hemmerle, R. Ahlbrand, S. L. Bronson, K. H. Lundgreen, N. M. Richtand, K. B. Seroogy, Society for Neuroscience, 1/1/2009
• Effect of risperidone, L-NAME or prenatal immune activation on the MK-801-induced increase in extracellular glutamate in the prefrontal cortex.
  Nicole Roenker, Rebecca Ahlbrand, Neil Richtand and Gary Gudelsky, Society for Neuroscience, 1/1/2009
• Stress following prenatal immune activation alters behavioral response to amphetamine.
  Stefanie L. Bronson, Rebecca Ahlbrand, Paul S. Horn, Joseph Kern, and Neil M. Richtand, Society for Neuroscience, 1/1/2009
• Environmental influence on maternal response in a prenatal immune activation model of schizophrenia.
  Bronson, S. L., Ahlbrand, R., Horn, P.S., Kern, J.R., Roenker, N.L., and Richtand, N.M., Biological Psychiatry, 1/1/2009
• Pharmacological intervention on a moving target: animal models with developmental relevance to schizophrenia.
  Neil M. Richtand, Rebecca Ahlbrand, Paul Horn, Kevin Stanford, Rabindra Tambyraja, Robert K. McNamara, and Gary A. Gudelsky, International Congress On Schizophrenia Research, 1/1/2009
• Primary Prevention with Risperidone and Paliperidone in a Prenatal Immune Activation Animal Model of Schizophrenia.
  Neil M. Richtand, Rebecca Ahlbrand, Kevin Stanford, and Robert K. McNamara, Soc. for Biological Psychiatry, 1/1/2008
• Clinically-Relevant Omega-3 Fatty Acid Deficiency Increases the 5-HT2A:D2 Receptor Binding Ratio in Rat Prefrontal Cortex: Normalization by Omega-3 Repletion but not C...
  Robert K. McNamara, Jessica Able, Neil M. Richtand, and Beth Levant, Soc. for Biological Psychiatry, 1/1/2008
• Primary Prevention with Fluoxetine and Aripiprazole in a Prenatal Immune Activation Animal Model of Schizophrenia.
  Neil M. Richtand, Rebecca Ahlbrand, Kevin Stanford, Rabindra Tambyraja, and Robert K. McNamara, Soc. for Biological Psychiatry, 1/1/2008
• Primary Prevention in a Prenatal Immune Activation Animal Model of Schizophrenia.
  Neil M. Richtand, Rebecca Ahlbrand, Kevin Stanford, and Robert K. McNamara, Meeting of the American College of Neuropsychopharmacology, 1/1/2007
• Chronic Risperidone has Reduced Efficacy in Omega-3 Fatty Acid Deficient Rats.
  Robert K. McNamara, Jessica Able, Neil M. Richtand, and Beth Levant, Meeting of the American College of Neuropsychopharmacology, 1/1/2007
• Dopaminergic Regulation of Dopamine D3 and D3nf Receptor mRNA Expression.
  N. M. Richtand, Y. Liu, R. Ahlbrand, J. R. Sullivan, A.H. Newman and R. K. McNamara, Soc. for Biological Psychiatry, 1/1/2007
• Dopamine and Serotonin Receptor Binding and Antipsychotic Efficacy.
  N.M. Richtand, J, Welge, A. Logue, P. Keck, S. Strakowski, and R.K. McNamara, Soc. for Biological Psychiatry, 1/1/2007
• Join now to see all

Lectures

• "Brain, immunology, and behavior ." 
  Nashville, TN - 6/12/2013
• "The new neurobiology of drug abuse: the immune system, inflammation, stress, and reward." 
  Las Vegas, NV - 3/6/2013
• "Microglia, inflammation, and mental illness: the neurobiology of prenatal immune activation." 
  San Diego, CA - 8/22/2012
• "Inflammation, stress, and mental illness: the neurobiology of prenatal immune activation." 
  Newark, NJ - 5/14/2012
• "Inflammation, stress, and drugs: the neurobiology of prenatal immune activation." 
  University of Kentucky, Lexington, KY - 4/12/2012
• "Schizophrenia: Disease Neurochemistry." 
  Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, - 10/21/2011
• Grand Rounds: "A link between inflammation and mental illness: exploring the neurobiology of prenatal immune activation." 
  Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine - 10/13/2010
• "Prenatal immune activation: a neurobiology linking inflammation and mental illness?" 
  San Diego, CA - 7/9/2010
• Grand Rounds: "Schizophrenia as a Developmental Disorder: Implications for Prevention and Treatment." 
  Psychiatry Department, Cincinnati Children's Hospital Medical Center, Cincinnati, OH - 11/11/2009
• "Schizophrenia as a Developmental Disorder: Implications for Prevention and Treatment." 
  Augusta, GA - 7/16/2009
• "Schizophrenia Prevention: Still Mission Impossible?" 
  San Diego, CA - 3/29/2009
• "Pharmacological intervention on a moving target: animal models with developmental relevance to schizophrenia." 
  San Diego, CA - 3/29/2009
• "Antipsychotic Medication Use in the Elderly" 
  Deadwood, SD - 2/28/2009
• "Schizophrenia Prevention: Can We Change the Course of Mental Illness? Using Animal Models to Identify Pharmacological Treatment Options." 
  2/23/2008
• "Can We Alter the Course of Psychiatric Illness? Looking Towards the Future, Using Animal Models with Relevance to Schizophrenia and Drugs of Abuse." 
  Department of Veteran's Affairs Hunter Holmes McGuire Medical Center, Richmond, VA - 1/10/2008
• Neuroscience Grand Rounds: "Antipsychotic Dosing and Side-Effect Management: Improving Patient Outcomes." 
  Evanston Hospital, Evanston, IL - 11/6/2007
• Psychiatry Service Grand Rounds: "Psychotic Illness, Cognition, and Functional Outcomes." 
  Department of Veteran's Affairs Medical Center, Washington, DC - 10/30/2007
• Grand Rounds: "First-Episode Schizophrenia: Can We Change the Course of Illness? Using Animal Models to Identify Pharmacological Treatment Options." 
  Washtenaw County Department of Mental Health, Washtenaw County, MI - 10/18/2007
• Grand Rounds: "Primary Prevention in Schizophrenia: Using Developmental Animal Models to Inform Pharmacological Treatment Options." 
  Department of Psychiatry, University of Alabama, Birmingham School of Medicine, Birmingham, AL - 10/16/2007
• Neuroscience Grand Rounds: "Managing Chronic Depression: Treating to Remission." 
  Our Lady of Bellefonte Hospital, Ashland, KY - 9/23/2007
• Grand Rounds: "Cardiovascular and Metabolic Risk in People with Severe Mental Illness." 
  Psychiatry Department, Metropolitan State Hospital, Norwalk, CA - 9/19/2007
• Grand Rounds: "Addressing Metabolic Disturbances With Antipsychotic Treatments." 
  Psychiatry Department, Euclid Hospital, Euclid, OH - 3/22/2007
• Neuroscience Grand Rounds: "Tailored Management of Schizophrenia in the Real World: A Naturalistic Approach." 
  San Joaquin County Behavioral Health Services, Stockton, CA - 3/8/2007
• Grand Rounds: "Assessing Antipsychotic Therapy in Bipolar Disorder." 
  Psychiatry Department, Colorado Mental Health Institute, Pueblo, CO - 1/31/2007
• Neuroscience Grand Rounds: "Correlating Neurochemical and Clinical Effects in the Treatment of Schizophrenia and Psychotic Illness." 
  Jacobi Medical Center, Bronx, NY - 12/6/2006
• Join now to see all